The first transformation of an existing Bulgarian capital company into a company with variable capital – a recently adopted by the legislator new form of company – is a already a fact. While the general expectations are that this new form of company is available for original incorporation and transformation is expected after these cease to be start-ups, it may be also appropriate for reshaping the business opportunities of already incorporated companies, eligible under the law. Our client Praeva Biotech, formerly wholly owned limited liability company, will continue to develop its business in the area of biotech innovations by making use of the advantages, provided for a company with variable capital. This project was completed primarily by Ina Raikova from Spasov & Bratanov.

 

Date: March 2025

Source: Spasov & Bratanov Lawyers’ Partnership 

 

More Posts

Spasov & Bratanov Lawyers’ Partnership advised on issues of Bulgarian law “Bulgarian Energy Holding” EAD as the issuer of new Eurobond issue in the amount of EUR 800,000,000. The issue

Read More »

Spasov & Bratanov assisted the Legal Directorate of Nestle Bulgaria AD in the performance of a set of resolutions of the general meeting of the shareholders towards the implementation of

Read More »

  Уважаеми клиенти, партньори и колеги, Уведомяваме Ви, че установихме опити за фишинг атаки чрез използване на публично известните от уеб-страницата ни име, лого и данни за контакт на адвокатско

Read More »

Spasov and Bratanov successfully advised the International Finance Corporation and Raiffeisenbank International AG Austria on one of the most significant financing transactions of the year in Bulgaria: a €90 million

Read More »

Share: